Economic Modeling of Heart Failure Telehealth Programs: When Do They Become Cost Saving?

Abstract EN

Telehealth programs for congestive heart failure have been shown to be clinically effective.

This study assesses clinical and economic consequences of providing telehealth programs for CHF patients.

A Markov model was developed and presented in the context of a home-based telehealth program on CHF.

Incremental life expectancy, hospital admissions, and total healthcare costs were examined at periods ranging up to five years.

One-way and two-way sensitivity analyses were also conducted on clinical performance parameters.

The base case analysis yielded cost savings ranging from $2832 to $5499 and 0.03 to 0.04 life year gain per patient over a 1-year period.

Applying telehealth solution to a low-risk cohort with no prior admission history would result in $2502 cost increase per person over the 1-year time frame with 0.01 life year gain.

Sensitivity analyses demonstrated that the cost savings were most sensitive to patient risk, baseline cost of hospital admission, and the length-of-stay reduction ratio affected by the telehealth programs.

In sum, telehealth programs can be cost saving for intermediate and high risk patients over a 1- to 5-year window.

The results suggested the economic viability of telehealth programs for managing CHF patients and illustrated the importance of risk stratification in such programs.